Quantitative phosphoproteomic profiling of CCL5/CCR5 signaling cascade in melanoma cells - Top-Institutions - MDSpire

Quantitative phosphoproteomic profiling of CCL5/CCR5 signaling cascade in melanoma cells

  • By

  • Xie, Lifen

  • Zhu, Tianhui

  • He, An

  • Wu, Qin

  • Zeng, Jinfeng

  • Huang, Liqin

  • Zhang, Ling

  • Liu, Jie

  • June 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Melanoma

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Melanoma

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology
    • Genomics

  • #4

    German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ)

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Oncology
    • Cancer Research

  • #5

    The Ohio State University
    The Ohio State University

    Columbus, Ohio

    Key Differentiators

    • Oncology
    • Cancer Research

Original Source(s)

Quantitative phosphoproteomic profiling of CCL5/CCR5 signaling cascade in melanoma cells

  • by Xie, Lifen , Zhu, Tianhui , He, An , Wu, Qin , Zeng, Jinfeng , Huang, Liqin , Zhang, Ling , Liu, Jie

  • June 22, 2026

Related Content

Intercellular mitochondrial transfer in melanoma progression and therapeutic resistance: mechanisms and targeting potential

Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice

The study points to a possible off-the-shelf cell therapy for solid tumors

  • June 16, 2026

  • 3 min
Potential targets for boron transport in boron neutron capture therapy